Hydroxyzine Pamoate

Generic name

Hydroxyzine Pamoate

Covered by Medicare

Yes

Get a Medicare Quote

Average Annual Cost per Beneficiary

$41.46

Average cost per year*

Average Annual Cost per Dose

$0.15

4.69%

Average cost per beneficiary*

Manufacturer(s)

  • Avpak
  • Avkare
  • Amneal Pharmace
  • AHP
  • Impax/Amneal
  • Greenstone LLC.
  • Rising Pharm
  • Sandoz
  • Teva USA
  • Heritage Pharma
  • Major Pharmaceu
  • Mylan Instituti

What is Hydroxyzine Pamoate

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Drug Trends

*Origin of the terms and chart data used within this page: https://data.cms.gov/

Common Questions About Hydroxyzine Pamoate

Yes, Hydroxyzine Pamoate is covered by Medicare.

In 2021, the average cost per dose of Hydroxyzine Pamoate was $0.15.

The average dose of Hydroxyzine Pamoate received per year is 90,192,201 units

378,545 Medicare beneficiaries received Hydroxyzine Pamoate in 2021, which was a 0.06% from 2020

There were 1,369,197 claims made by Medicare beneficiaries, which is a 0.07% from 2020

The average spending amount per claim in 2021 was $11.46

The average Medicare spending per beneficiary amount for Hydroxyzine Pamoate was $41.46

The most expensive manufacturer of Hydroxyzine Pamoate is Avpak

Heritage Pharma is the least expensive manufacturer with an Average Spending Per Dosage Unit of $0.09

Sandoz received $6,396,672.78

The total amount spent on Hydroxyzine Pamoate by Medicare is $15,693,297.15

© 2021-2024 HealthInsurance.com, LLC

Privacy Policy  |  Terms and Conditions

GENERAL DISCLAIMERS

Healthinsurance.com is a commercial site designed for the solicitation of insurance from selected health insurance carriers and HealthInsurance.com, LLC is a licensed insurance agency. It is not a government agency. It is also not an insurer, or a medical provider. HealthInsurance.com, LLC is a licensed representative of Medicare Advantage (HMO, PPO, PFFS, and PDP) organizations that have a Medicare contract. Enrollment depends on the plan’s contract renewal.
We do not offer every plan available in your area. Currently we represent nine carrier plan organizations nationally. Please contact Medicare.gov, 1-800-MEDICARE, or your local State Health Insurance Program (SHIP) to get information on all of your options.
Alternatively, you may be referred, via a link, to a selected partner website, which is independently owned and operated and may have different privacy and terms of use policies from us.
If you provide your contact information to us, an insurance agent/producer or insurance company may contact you. If you do not speak English, language assistance service, free of charge, is available to you; contact the toll-free number listed above. This site is not maintained by or affiliated with the federal government's Health Insurance Marketplace website or any state government health insurance marketplace.
The plans we represent do not discriminate on the basis of race, color, national origin, age, disability, or sex. To learn more about a plan's nondiscrimination policy, please click here.
Not all plans offer all of these benefits. Benefits may vary by carrier and location. Limitations and exclusions may apply.
Multi-Plan_HIC_Web_M